2026 Hybrid European Bioassay Conference
19th Annual | Seville, Spain | 23-25 September 2026
Hotel Meliá Sevilla
Registration Early Bird Prices:Prices increase end-of-day April 24, 2026.
3-Day Event
Includes:
- Bioassay Workshops
- Scientific Poster Session
- Two days of Podium Presentations
- Two networking events
Group Discounts (only applicable to Industry tickets):
Quick Links
23-25 September 2026
Seville, Spain
Hybrid Conference
Deadlines
Abstract Submission: Feb. 20, 2026
Poster Submission: Sept. 2, 2026
Next Price Increase: Apr. 24, 2026
Registration Closes:
In-person closes Sept. 16, 2026
Virtual closes Sept. 18, 2026












Draft Agenda
Our Hybrid 2026 European Bioassay Conference draft agenda is here! Check the agenda for updates as we finalize our schedule.
Participating Companies:
- Novartis
- Sanofi
- AstraZeneca
- Richter BioLogics
- Genmab
- Eurofins
- Promega
- Stegmann Systems
- acCELLerate
- Bioassay GmbH
Hotel Information
A room block is reserved at the group rate of 180 EUR for a single, standard room and 200 EUR for a double, standard room per night. The room rates includes a buffet breakfast per person and 10% VAT per room. The room reservation deadline is Friday, 28 August 2026. After this date, reservations will be accepted on a space-available basis and at the best available rate. To make room reservations, please use the link provided below.
The room block will most likely be filled BEFORE the deadline; we recommend that attendees book their hotel accommodation well BEFORE the 28 August 2026 deadline. The Hotel Meliá Sevilla does require a credit card to guarantee your reservation. Reservations made for the hotel need to be cancelled 72 hours before your arrival for a full refund.
NOTE: Check-in time is 15:00 and check-out time is 12:00.
Hotel Meliá Sevilla
Calle Dr. Pedro de Castro, 1,
41004 Sevilla, Spain
Telephone: +34 954 42 15 11
Website: Meliá Sevilla
2026 EUB Exhibitors
2026 Planning Committee
Marie Gottar-Guiller
Novartis
Ulrike Herbrand
Charles River Labs
Sonja Klingelhöfer
Richter Biologics
Alex Knorre
Eurofins
Pierre Lebrun
Pharmalex
Laureen Little
BEBPA
Louise Pritchett
Novartis
Anton Stetsenko
BioQual Consulting
Lasse Waehrens
Novo Nordisk A/S